Guanglin D. Xiao

Key Laboratory Of Molecular Biology For Infectious Diseases
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The cWHV Model Preferentially Recapitulates Intrahepatic CD8 T-Cell Programs of the Immune-Active Phase of HBV Infection.

The cWHV Model Preferentially Recapitulates Intrahepatic CD8 T-Cell Programs of the Immune-Active Phase of HBV Infection.

Journal: Journal of hepatology

Published: May 21, 2026

Natural small molecule evodiamine alleviates liver fibrosis by targeting the ANXA2-p110α axis in hepatic stellate cells.

Natural small molecule evodiamine alleviates liver fibrosis by targeting the ANXA2-p110α axis in hepatic stellate cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 01, 2026

Diabetes Impairs the Virological Response in Patients with Chronic Hepatitis B: Glycemic Control as a Key Modifiable Risk Factor.

Diabetes Impairs the Virological Response in Patients with Chronic Hepatitis B: Glycemic Control as a Key Modifiable Risk Factor.

Journal: Journal of clinical medicine

Published: January 13, 2026

Transformation and evidence-based progress of chronic constipation treatment mode

Transformation and evidence-based progress of chronic constipation treatment mode

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: December 15, 2025

Identification of glycolysis-related clusters and immune cell infiltration in hepatic fibrosis progression using machine learning models and experimental validation.

Identification of glycolysis-related clusters and immune cell infiltration in hepatic fibrosis progression using machine learning models and experimental validation.

Journal: Frontiers in immunology

Published: August 13, 2025

A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?

A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?

Journal: Journal of hepatology

Published: September 05, 2024

Patients with HCC as an ideal study population to assess immune checkpoint inhibitors in hepatitis B.

Patients with HCC as an ideal study population to assess immune checkpoint inhibitors in hepatitis B.

Journal: Journal of hepatology

Published: August 28, 2024

Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis.

Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis.

Journal: International journal of public health

Published: August 04, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026